There has been a ceaseless development in gene modification strategy beginning from restriction endonucleases, transgenic breeding, RNAi advances to the currently engineered endonucleases. Over the last few decades, Gene editing took a new turn with the discovery of CRISPR and its variant Cas9. CRISPR not only gave a new image to gene editing but also raised the standards for new findings. CRISPR and CRISPR-associated (Cas) genes market is expected to hit whopping value of USD 4.09 billion by 2025. The influencing factor for the escalated growth of CRISPR-Cas system is progressive gene therapy, disease prevalence, GM crops, grants/funding etc.
# The key players (Maximum filing) in CRISPR-Cas system-based genome editing is Broad Institute, MIT, Harvard college, Dupont, University California etc.
The report studies CRISPR Technology in various below stated segments:
By End User
### IEBS offers tailored information as per client needs viz. additional company profiling (up to 10), partner identification, regions which are untapped, key strategies employed by the target companies for their sustenance in the studied field etc.